Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02685566 · ClinicalTrials.gov registry record · NA
Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training Program
A NA study of Breast Cancer, sponsored by Fujifilm Medical Systems USA.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 5
- Study locations
NCT02685566: Completed NA study of Breast Cancer, sponsored by Fujifilm Medical Systems USA.
NCT02685566 is a NA study of Breast Cancer that has completed, run by Fujifilm Medical Systems USA. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02685566, a NA study of Breast Cancer, has completed, sponsored by Fujifilm Medical Systems USA.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this pilot is to assess the adequacy of the Fujifilm DBT Reader Study Training program to ensure that Readers participating in the Fujifilm DBT pivotal trial are properly trained in the reading and interpretation of FFDM and DBT images.
Conditions Studied
Interventions
- DEVICE FFDM Plus DBT
- DEVICE FFDM
Study Locations (5)
Arizona
- Scottsdale Medical Imaging, Limited (SMIL) - Scottsdale
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
New York
- Elizabeth Wende Breast Care, LLC (EWBC) - Rochester
North Carolina
- University of North Carolina - at Chapel Hill - Chapel Hill
Texas
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-08 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02685566
The ClinicalTrials.gov registry entry for NCT02685566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Fujifilm Medical Systems USA, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which FFDM Plus DBT is the first listed.
NCT02685566 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Iowa, New York.
Frequently Asked Questions
What is clinical trial NCT02685566 about?
NCT02685566 is a clinical study titled "Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training Program". The purpose of this pilot is to assess the adequacy of the Fujifilm DBT Reader Study Training program to ensure that Readers participating in the Fujifilm DBT pivotal trial are properly trained in the reading and interpretation of FFDM and DBT images.
What is the current status of trial NCT02685566?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-08. Estimated completion is 2015-10.
What conditions does trial NCT02685566 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02685566?
The interventions under investigation include: FFDM Plus DBT (DEVICE), FFDM (DEVICE).
Who is sponsoring clinical trial NCT02685566?
This trial is sponsored by Fujifilm Medical Systems USA, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02685566 being conducted?
This trial has 5 study locations across Arizona, Iowa, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.